Agence européenne du médicament - activities

Covid: a new nanotechnology-based vaccine on the horizon?

Although Covid-19 no longer impacts our lives as much as it has over the past two years, the fight against the virus is far from over. The European Medicines Agency has mooted a new nanotechnology-based vaccine.

Covid: Sanofi's vaccine soon to be allowed in Europe

Is the Sanofi vaccine soon to be marketed? This Tuesday July 20, 2021, the European Medicines Agency has announced they are to launch a rolling review of results from phase 3 of the ongoing clinical trial of the French laboratory candidate vaccine in order to allow or not marketing issuance as soon as possible. Issuance could actually occur in the first six months of 2022, although it has been announced for late 2021.

Covid: The first deliveries of the Novavax vaccines planned for the end of the week in France

Granted marketing authorizatoin by the European Medicines Agency and the Haute Autorité de Santé, Nuvaxovid, aka Novavax's "subunit" vaccine, which was expected to be delivered in France as early as the beginning of February, is eventually to be delivered by the end of the week.

Covid: EMA approved use of RoActemra (Tocilizumab) for severe disease

Is Tocilizumab – a Covid therapy – still under rolling review? The European Medicines Agency announced they have approved RoActemra (Tocilizumab) on hospitalized severe Covid patients. This anti-inflammatory therapy usually used against arthritis is able to bloc interleukin-6 and prevent cytokine storms, namely a secondary inflammation of the lungs.

Coronavirus: Two antibody therapies given the green light in Europe

This is a first in the fight against coronavirus in Europe. Two antibody therapies have been approved this Thursday November 11, 2021 by the European Medicines Agency. These two Covid-19 solutions are given the green light for marketing in Europe.

Vaccine: Guillain-Barré syndrome, a new rare side-effect associated with AstraZeneca

The European Medicines Agency has listed another side effect to the list of adverse effects associated with the AstraZenca vaccine: Guillain-Barré syndrome has been reported in 833 people in over 592 million doses injected.

Coronavirus: The European Union ordered a new antibody therapy

This Wednesday July 28, the European Union announced they have secured a deal for a new experimental coronavirus therapy, Sotrovimab, developed by UK laboratory GSK. A promising monoclonal antibody therapy.

Covid: two doses of vaccine seem to protect against the Delta variant, the EMA claims

As the Indian variant is spreading more every day, this Thursday July 1, 2021, the European Medicines Agency claims two doses of vaccine seem to protect against the Delta variant.

AstraZeneca/Janssen: thromboses explained by German searchers

German scientists are said to have discovered where thromboses caused by the AstraZeneca and Janssen vaccines come from, explaining they are caused by the vector used, the adenovirus. Keep reading to find out more.

Covid: EMA allows stocking Pfizer vaccine in standard refrigerators

This Friday March 26, the European Medicines Agency announced Pfizer/BioNTech Covid vaccine can be stored at higher temperatures than recommended so far, for two weeks, making storage easier. An authorization following recommendations issued in mid-February by the American laboratory in terms of storage.

AstraZeneca vaccine must remain limited to people aged 55+ by the Haute Autorité de Santé says

The Haute Autorité de Santé "maintains the limit of 55 years of age for Vaxzevria", aka AstraZeneca's vaccine, because of the benefit/risk ratio related to rare cases of thrombosis. This notice follows the government's demand as they wish to extend its access to all volunteering French as it is already happening in Germany.

Covid: vaccination, AstraZeneca... Olivier Véran's address this Thursday April 22

On the occasion of a press brief held this Thursday April 22, French Health Minister Olivier Véran addressed the vaccination situation in France, and answered questions French may have, especially about the vaccines and AstraZeneca. Keep reading to find out more!

Johnson & Johnson vaccine to be given starting late April in France

During the press brief held this Thursday April 22, Health Minister Olivier Véran announced the Johnson & Johnson vaccine will start to be given starting this Saturday April 24 in pharmacies. The vaccine arrives after being assessed safe on Tuesday April 20 by the European Medicines Agency.

Johnson & Johnson vaccine still halted by the FDA in the USA

This Thursday April 15, 2021, the Food & Drug Administration (FDA) has announced the Johnson & Johnson vaccine was still halted - as decided two days ago - for another week in the USA after suspicious cases of thrombosis in vaccinated people have been reported. Yet, the vaccine enjoyed emergency use approval by the regulator this past February 27.

AstraZeneca: thromboses considered as "rare side effects" of the vaccine, EMA says

After the Medicines Agency confirmed the existence of a "rare" risk of atypical thrombosis, this Tuesday April 6, the European Medicines Agency declares there is indeed a link between the vaccine and the creation of blood clots. The day after, on Wednesday April 7, the European regulator announced in a press brief they list blood clots as one of vaccine rare adverse effects.

Covid: Russian Sputnik V vaccine not to be approved before late June, Clément Beaune says

This Tuesday January 19, 2021, as the Russian authorities sought approval for issuing their Covid vaccine, Sputnik V, mostly developed by the Russian direct investment fund, from the European Medicines Agency, French State Secretary for European Affairs Clément Beaune announced the vaccine was unlikely to be approve before late June.

Covid: AstraZeneca vaccine to be renamed Vaxzevria

This Tuesday March 30, the European Medicines Agency announced the AstraZeneca vaccine changed its trade name to become Vaxzevria.

Covid and vaccination: “There is no other solution but a European solution”, Macron claims

During the European Council about Covid held this Thursday March 25, French President Emmanuel Macron advocated for the EU’s health policy explaining vaccination could only be completed on a European scale.

AstraZeneca reviews data and announces vaccine is 76% effective

As this Monday March 22, AstraZeneca laboratory stated their vaccine was 79% effective and show no risk of thromboses (blood clots), this Thursday March 25, the Swedish-British laboratory reviewed data as required by the NIAID (National Institute of Allergy and Infections Diseases), and announced updated data including vaccine was 76% effective.

Covid: AstraZeneca vaccine approved by France's Haute Autorité de Santé for people under 65

Appproved by the European Medicines Agency since this Friday January 29, Covid vaccine by AstraZeneca has been approved, this Tuesday February 2, by the Haute Autorité de Santé only for people under the age of 65. It is to arrive in France from February 8 - according to Secretary of State for European Affairs Clément Beaune.